TrialPath
Recruiting

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

NCT07184944 · Sanofi
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Phase 3, Maintenance Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
About this study
This is a multicenter, randomized, double-blind, placebo-controlled, maintenance, Phase 3 study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn's Disease (CD). Study details include: The study duration may be up to 286 weeks including: * 40-week Pivotal Maintenance Sub-Study * 240-week Open-Label Extension (OLE) Sub-Study * 45-day Follow-Up visit Note: For the participants who do not enroll into OLE Sub-Study, the duration will be up to 46 weeks, including the 40-week maintenance period and a 45-day follow-up visit. The treatment duration may be up to 280 weeks including: * 40 weeks in the Pivotal Maintenance Sub-Study * 240 weeks in OLE Sub-Study The total number of on-site visits will be up to 43: - 21 visits in the Pivotal Maintenance Sub-Study - 22 visits in the OLE Sub-Study
Eligibility criteria
Inclusion Criteria: * Participants aged ≥18 and ≤80 years of age at Baseline. (Where locally permissible, participants 16 to \<18 years of age who meet the definition of Tanner stage 5 for development) * Pivotal Maintenance Sub-Study: Participants who achieved clinical response and completed endoscopy at the end of STARSCAPE-1 * OLE Sub-Study: Participants who complete the Pivotal Maintenance Sub-Study or participation in the TV48574-IMM-20038 Study Exclusion Criteria: * Participants with medical or compliance conditions that are deemed unsuitable for the study by the investigator * Participants with a known hypersensitivity to duvakitug that makes the participant unsuitable for the study by the investigator The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial
Study design
Enrollment target: 751 participants
Allocation: randomized
Masking: quadruple
Age groups: child, adult, older_adult
Timeline
Starts: 2026-01-22
Estimated completion: 2034-03-20
Last updated: 2026-11-20
Interventions
Drug: DuvakitugDrug: Placebo
Primary outcomes
  • • Co-primary endpoints US/FDA: Pivotal Maintenance Sub-Study Cohort 1 Proportion of participants achieving clinical remission (CDAI) at Week 40 (Week 40)
  • • Proportion of participants achieving Endoscopic Response (SES-CD) at Week 40 (Week 40)
  • • Co-primary endpoints EU/EMA: Pivotal Maintenance Sub-Study Cohort 1 Proportion of participants achieving clinical remission per PRO-2 at Week 40 (Week 40)
Sponsor
Sanofi · industry
With: Teva Branded Pharmaceutical Products R&D LLC
Contacts & investigators
ContactTrial Transparency email recommended (Toll free for US & Canada) · contact · Contact-US@sanofi.com · 800-633-1610
All locations (152)
Peak Gastroenterology Associates - Colorado Springs-Site Number: 8400039Recruiting
Colorado Springs, Colorado, United States
Novum Research, LLC-Site Number: 8400003Recruiting
Clermont, Florida, United States
Clinical Research of Osceola-Site Number: 8400013Recruiting
Kissimmee, Florida, United States
Columbus Clinical Services LLc-Site Number: 8400038Recruiting
Miami, Florida, United States
Sylvester Comprehensive Cancer Center - A University of Miami Hospital and Clinics Facility - Miami-Site Number: 8400111Recruiting
Miami, Florida, United States
Bioresearch Partner-Kendale Lakes-Site Number: 8400053Recruiting
Miami, Florida, United States
Orlando Health, Inc., Digestive Health Institute-Site Number: 8400084Recruiting
Orlando, Florida, United States
NMC Research LLC-Site Number: 8400033Recruiting
Tampa, Florida, United States
Midwest Digestive Health and Nutrition-Site Number: 8400136Recruiting
Des Plaines, Illinois, United States
Illinois Gastroenterology Group d/b/a GI Alliance - Gurnee-Site Number: 8400049Recruiting
Gurnee, Illinois, United States
Gastroenterology Health Partners, PLLC - New Albany-Site Number: 8400100Recruiting
New Albany, Indiana, United States
GI Alliance - Baton Rouge-Site Number: 8400129Recruiting
Baton Rouge, Louisiana, United States
Texas Digestive Disease Consultants, PLLC d/b/a GI Alliance - Mandeville-Site Number: 8400128Recruiting
Mandeville, Louisiana, United States
GI Alliance - Metairie-Site Number: 8400124Recruiting
Metairie, Louisiana, United States
Delta Research Partners-Site Number: 8400087Recruiting
Monroe, Louisiana, United States
BVL Clinical Research-Site Number: 8400005Recruiting
Liberty, Missouri, United States
Gateway Gastroenterology-Site Number: 8400097Recruiting
St Louis, Missouri, United States
MedTraits NY-Site Number: 8400045Recruiting
Maspeth, New York, United States
NYU Langone Health-Site Number: 8400091Recruiting
New York, New York, United States
Weill Cornell Medicine - NewYork-Presbyterian Hospital-Site Number: 8400040Recruiting
New York, New York, United States
New York Gastroenterology Associates-Site Number: 8400009Recruiting
New York, New York, United States
UNC Hospitals, The University of North Carolina at Chapel Hill-Site Number: 8400074Recruiting
Chapel Hill, North Carolina, United States
Cross Creek Medical Clinic-Site Number: 8400057Recruiting
Fayetteville, North Carolina, United States
Ohio Gastroenterology Group Inc.-Site Number: 8400006Recruiting
Columbus, Ohio, United States
Medical Associates Research Group-Site Number: 8400063Recruiting
Columbus, Ohio, United States
OSU Wexner Medical Center-Site Number: 8400077Recruiting
Columbus, Ohio, United States
North Shore Gastroenterology Research-Site Number: 8400130Recruiting
Westlake, Ohio, United States
University of Pennsylvania School of Medicine-Site Number: 8400072Recruiting
Philadelphia, Pennsylvania, United States
The Allegheny Health Network (AHN) Center for Digestive Health-Site Number: 8400107Recruiting
Pittsburgh, Pennsylvania, United States
University Gastroenterology - GI Alliance-Site Number: 8400103Recruiting
Providence, Rhode Island, United States
GI Alliance - Lubbock-Site Number: 8400092Recruiting
Lubbock, Texas, United States
SMS Clinical Research-Site Number: 8400035Recruiting
Mesquite, Texas, United States
Gastroenterology Research of San Antonio LLC-Site Number: 8400054Recruiting
San Antonio, Texas, United States
Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake-Site Number: 8400101Recruiting
Southlake, Texas, United States
Tyler Research Institute LLC-Site Number: 8400095Recruiting
Tyler, Texas, United States
The Vancouver Clinic Inc. P.S.-Site Number: 8400090Recruiting
Vancouver, Washington, United States
Gastroenterology Associates of Western Michigan-Site Number: 8400060Recruiting
Wyoming, Wyoming, United States
Investigational Site Number : 0360001Recruiting
South Brisbane, Queensland, Australia
Investigational Site Number : 0400002Recruiting
Salzburg, Australia
Investigational Site Number : 0400007Recruiting
Vienna, Australia
Investigational Site Number : 0400001Recruiting
Vienna, Austria
Investigational Site Number : 0560004Recruiting
Liège, Belgium
Investigational Site Number : 0560003Recruiting
Yvoir, Belgium
Investigational Site Number: 0760005Recruiting
Juiz de Fora, Minas Gerais, Brazil
Investigational Site Number: 0760003Recruiting
Caxias do Sul, Rio Grande do Sul, Brazil
Investigational Site Number: 0760002Recruiting
Barretos, São Paulo, Brazil
Investigational Site Number: 0760010Recruiting
Brasília, Brazil
Investigational Site Number: 0760001Recruiting
Goiânia, Brazil
Investigational Site Number: 0760007Recruiting
Porto Alegre, Brazil
Sao Jose do Rio Preto Regional Faculty of Medicine Foundation-Site Number: 0760006Recruiting
São José do Rio Preto, Brazil
Investigational Site Number: 0760014Recruiting
São Paulo, Brazil
Investigational Site Number: 0760011Recruiting
Teresina, Brazil
Investigational Site Number : 1000003Recruiting
Gorna Oryahovitsa, Oblast Veliko Tirnovo, Bulgaria
Investigational Site Number : 1000007Recruiting
Rousse, Bulgaria
Investigational Site Number : 1000001Recruiting
Sofia, Bulgaria
Investigational Site Number : 1240004Recruiting
Edmonton, Canada
Investigational Site Number : 1240009Recruiting
Hamilton, Canada
Investigational Site Number : 1240011Recruiting
London, Canada
Investigational Site Number : 1240013Recruiting
London, Canada
Investigational Site Number : 1240002Recruiting
Montreal, Canada
Investigational Site Number : 1240006Recruiting
New Westminster, Canada
Investigational Site Number : 1240003Recruiting
Toronto, Canada
Investigational Site Number : 1520003Recruiting
Santiago, Chile
Investigational Site Number : 1520001Recruiting
Viña del Mar, Chile
Investigational Site Number : 1560001Recruiting
Chengdu, Sichuan, China
Investigational Site Number : 1560029Recruiting
Taizhou, Zhejiang, China
Investigational Site Number : 1560009Recruiting
Guangzhou, China
Investigational Site Number : 1560002Recruiting
Guangzhou, China
Investigational Site Number : 1560005Recruiting
Hangzhou, China
Investigational Site Number : 1560026Recruiting
Huizhou, China
Investigational Site Number : 1560030Recruiting
Mianyang, China
Investigational Site Number : 1560019Recruiting
Nanjing, China
Investigational Site Number : 1560020Recruiting
Shanghai, China
Investigational Site Number : 1560007Recruiting
Wenzhou, China
Investigational Site Number : 1560018Recruiting
Wuxi, China
Investigational Site Number : 2030003Recruiting
Brno, Czechia
Investigational Site Number: 2030011Recruiting
Hradec Králové, Czechia
Investigational Site Number : 2030013Recruiting
Prague, Czechia
Investigational Site Number : 2030002Recruiting
Slaný, Czechia
Investigational Site Number : 2680006Recruiting
Tbilisi, Georgia
Investigational Site Number : 2680001Recruiting
Tbilisi, Georgia
Investigational Site Number : 2680008Recruiting
Tbilisi, Georgia
Investigational Site Number : 2680003Recruiting
Tbilisi, Georgia
Investigational Site Number : 2680005Recruiting
Tbilisi, Georgia
Investigational Site Number : 2680009Recruiting
Tbilisi, Georgia
Investigational Site Number : 2680002Recruiting
Tbilisi, Georgia
Investigational Site Number : 2680004Recruiting
Tbilisi, Georgia
Investigational Site Number : 2760009Recruiting
Tübingen, Baden-Wurttemberg, Germany
Investigational Site Number : 2760005Recruiting
Ulm, Baden-Wurttemberg, Germany
Investigational Site Number : 2760015Recruiting
Leipzig, Saxony, Germany
Investigational Site Number : 2760020Recruiting
Leipzig, Saxony, Germany
Investigational Site Number : 2760001Recruiting
Kiel, Schleswig-Holstein, Germany
Investigational Site Number : 3480002Recruiting
Budapest, Hungary
Investigational Site Number : 3480003Recruiting
Tatabánya, Hungary
Investigational Site Number : 3760001Recruiting
Jerusalem, Israel
Investigational Site Number : 3760002Recruiting
Tel Aviv, Israel
Investigational Site Number : 3800003Recruiting
Rozzano, Italy
Investigational Site Number : 3800005Recruiting
Turin, Italy
Investigational Site Number : 3920030Recruiting
Kamakura, Japan
Investigational Site Number : 3920013Recruiting
Nishinomiya, Japan
Investigational Site Number : 3920014Recruiting
Saga, Japan
Investigational Site Number : 3920009Recruiting
Tsu, Japan
Investigational Site Number : 4400001Recruiting
Kaunas, Lithuania
Investigational Site Number : 4980002Recruiting
Chisinau, Moldova
Investigational Site Number : 4980003Recruiting
Chisinau, Moldova
Investigational Site Number : 4980004Recruiting
Chisinau, Moldova
Investigational Site Number : 5280003Recruiting
Tilburg, Netherlands
Investigational Site Number : 5540003Recruiting
Lower Hutt, New Zealand
Investigational Site Number : 6160026Recruiting
Bydgoszcz, Poland
Investigational Site Number : 6160013Recruiting
Elblag, Poland
Investigational Site Number : 6160014Recruiting
Katowice, Poland
Investigational Site Number : 6160030Recruiting
Kłodzko, Poland
Investigational Site Number : 6160034Recruiting
Lublin, Poland
Investigational Site Number : 6160027Recruiting
Nowy Targ, Poland
Investigational Site Number : 6160032Recruiting
Olsztyn, Poland
Investigational Site Number : 6160025Recruiting
Rzeszów, Poland
Investigational Site Number : 6160004Recruiting
Sopot, Poland
Investigational Site Number : 6160007Recruiting
Staszów, Poland
Investigational Site Number : 6160020Recruiting
Szczecin, Poland
Investigational Site Number : 6160023Recruiting
Torun, Poland
Investigational Site Number : 6160012Recruiting
Wadowice, Poland
Investigational Site Number : 6160008Recruiting
Warsaw, Poland
Investigational Site Number : 6160006Recruiting
Wroclaw, Poland
Investigational Site Number : 6160037Recruiting
Wroclaw, Poland
Investigational Site Number : 6160028Recruiting
Wroclaw, Poland
Investigational Site Number : 6160017Recruiting
Wroclaw, Poland
Investigational Site Number : 6160021Recruiting
Zamość, Poland
Investigational Site Number : 6880002Recruiting
Belgrade, Serbia
Investigational Site Number : 7030001Recruiting
Bratislava, Slovakia
Investigational Site Number : 7030002Recruiting
Prešov, Slovakia
Investigational Site Number : 7030004Recruiting
Prešov, Slovakia
Investigational Site Number : 7100002Recruiting
Cape Town, South Africa
Investigational Site Number : 7100004Recruiting
Durban, South Africa
Investigational Site Number : 7100001Recruiting
Kempton Park, South Africa
Investigational Site Number : 4100008Recruiting
Busan, South Korea
Investigational Site Number : 4100007Recruiting
Gwangju, South Korea
Investigational Site Number : 4100006Recruiting
Seoul, South Korea
Investigational Site Number : 4100001Recruiting
Seoul, South Korea
Investigational Site Number : 4100002Recruiting
Seoul, South Korea
Investigational Site Number : 7240002Recruiting
Huelva, Spain
Investigational Site Number : 7240004Recruiting
Madrid, Spain
Investigational Site Number : 7240003Recruiting
Santiago de Compostela, Spain
Investigational Site Number : 7560002Recruiting
Basel, Switzerland
Investigational Site Number : 7560001Recruiting
Bern, Switzerland
Investigational Site Number : 1580005Recruiting
Changhua County, Taiwan
Investigational Site Number : 8040001Recruiting
Kyiv, Ukraine
Investigational Site Number : 8040013Recruiting
Kyiv, Ukraine
Investigational Site Number : 8040004Recruiting
Lviv, Ukraine
Investigational Site Number : 8040005Recruiting
Lviv, Ukraine
Investigational Site Number : 8040006Recruiting
Uzhhorod, Ukraine
Investigational Site Number : 8040010Recruiting
Vinnytsia, Ukraine
Investigational Site Number : 8040009Recruiting
Vinnytsia, Ukraine